Latest Articles
- Research ArticlesRole of Chitinase 3–like 1 as a Biomarker in Multiple SclerosisA Systematic Review and Meta-analysisStefano Floro, Tiziana Carandini, Anna Margherita Pietroboni, et al.May 09, 2022
- Clinical/Scientific NoteLongitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or FingolimodVirginia Palomares Cabeza, Laura Y.L. Kummer, Luuk Wieske, et al.May 06, 2022
- Research ArticleNeurosarcoidosis of the Cauda EquinaClinical Course, Radiographic and Electrodiagnostic Findings, Response to Treatment, and OutcomesGabriela Alejandra Bou, Rocio Garcia-Santibanez, Alexander Jordan Castilho, et al.April 29, 2022
- Acknowledgment to ReviewersNeurology® Neuroimmunology & Neuroinflammation Acknowledgment to ReviewersJosep O. DalmauApril 27, 2022
- Research ArticleHeterogeneity of Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Patients With Myasthenia GravisAbeer H. Obaid, Chryssa Zografou, Douangsone D. Vadysirisack, et al.April 26, 2022
- Research ArticlePure Relapsing Short MyelitisPart of the Multiple Sclerosis Spectrum or New Entity?Zélia Poullet, Julie Pique, Adil Maarouf, et al.April 26, 2022
- EditorialProgrammed Cell Death Protein 1–Positive CD8+ T Cells in Multiple SclerosisExhausted Fighters or PeacekeepersJoost Smolders, Jörg HamannApril 22, 2022
- Clinical/Scientific NoteRelapsing and Immune-Responsive Paroxysmal Jaw Clonus With Blepharospasm and Sialorrhea Associated With D2R AutoantibodiesYue Liu, Xiaoting Hao, Dong Zhou, et al.April 22, 2022
- Clinical/Scientific NoteAutoimmune Encephalitis With mGluR1 Antibodies Presenting With Epilepsy, but Without Cerebellar SignsA Case ReportAnita M. Vinke, Shenghua Zong, Josien H. Janssen, et al.April 21, 2022
Pages
Advertisement
Dr. Daniel Friedman and Dr. Sharon Chiang